Same Day Discharge for Wedge Resection

NCT05067738 | Completed

• 1 other identifier: v1.0 7 July 2021
• Study Type: interventional
• Target: 54
• Locations: 1 country
• Sites: 1

Brief Summary

Monitoring carefully selected participants to determine if participants can be safely discharged the same day of pulmonary resection

Conditions

Surgery; Minor; Lung Cancer

Outcome Measures

Primary Outcomes (1)

• Rate of successful same day discharge

  These patients will have their chest tube removed once they meet chest tube removal criteria and will be discharged home once they meet discharge criteria.

  2 years

Study Arms (1)

Discharge

OTHER

Phase 1-Patients will continue to be admitted after their surgery as is the current practice. Phase 2-Patients will have their chest tube removed once they meet chest tube removal criteria and will be discharged home once they meet discharge criteria.

Other: same day discharge

Interventions

same day discharge OTHER

same day discharge

Discharge

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged 18 years of age and older who are scheduled to undergo an elective minimally invasive wedge resection of their lung.

You may not qualify if:

• Pulmonary function tests demonstrating forced expiratory volume in 1 second (FEV1) \<50% predicted, FEV1 \<1.5L and/or diffusion lung capacity of carbon monoxide (DLCO) \<50% predicted.
• Patient receives an intraoperative pleurodesis.
• Conversion to open thoracotomy or mini thoracotomy intraoperatively.
• Active pregnancy.
• Thoracic Revised Cardiac Risk Index Score (ThRCRI)8 \>2.
• Underlying cognitive disorder resulting in inability to complete activities of daily living.

Sponsors & Collaborators

• London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's: lead

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Rahul Nayak

  Western University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SEQUENTIAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director of Research

Model Details: 2 phases

Study Record Dates

• First Submitted: September 24, 2021
• First Posted: October 5, 2021
• Study Start: February 1, 2022
• Primary Completion: January 15, 2024
• Study Completion: March 31, 2024
• Last Updated: May 31, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)